- Home
- DNA vs HPP Comparison
DNA vs HPP Comparison
Compare DNA & HPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNA
- HPP
- Stock Information
- Founded
- DNA 2008
- HPP 1997
- Country
- DNA United States
- HPP United States
- Employees
- DNA N/A
- HPP N/A
- Industry
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- HPP Real Estate
- Sector
- DNA Health Care
- HPP Finance
- Exchange
- DNA Nasdaq
- HPP Nasdaq
- Market Cap
- DNA 895.1M
- HPP 1.0B
- IPO Year
- DNA N/A
- HPP 2010
- Fundamental
- Price
- DNA $13.23
- HPP $2.60
- Analyst Decision
- DNA Strong Sell
- HPP Hold
- Analyst Count
- DNA 1
- HPP 11
- Target Price
- DNA $9.00
- HPP $3.04
- AVG Volume (30 Days)
- DNA 1.8M
- HPP 3.7M
- Earning Date
- DNA 11-11-2025
- HPP 11-05-2025
- Dividend Yield
- DNA N/A
- HPP N/A
- EPS Growth
- DNA N/A
- HPP N/A
- EPS
- DNA N/A
- HPP N/A
- Revenue
- DNA $230,815,000.00
- HPP $792,977,000.00
- Revenue This Year
- DNA N/A
- HPP N/A
- Revenue Next Year
- DNA $14.41
- HPP $6.87
- P/E Ratio
- DNA N/A
- HPP N/A
- Revenue Growth
- DNA 25.21
- HPP N/A
- 52 Week Low
- DNA $5.00
- HPP $1.78
- 52 Week High
- DNA $17.58
- HPP $5.00
- Technical
- Relative Strength Index (RSI)
- DNA 48.01
- HPP 44.67
- Support Level
- DNA $13.16
- HPP $2.48
- Resistance Level
- DNA $16.50
- HPP $2.78
- Average True Range (ATR)
- DNA 1.46
- HPP 0.12
- MACD
- DNA -0.22
- HPP -0.01
- Stochastic Oscillator
- DNA 15.37
- HPP 35.82
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
About HPP Hudson Pacific Properties Inc.
Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.